Repasky EA - Search Results

1

Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature.

Kokolus KM, Capitano ML, Lee CT, Eng JW, Waight JD, Hylander BL, Sexton S, Hong CC, Gordon CJ, Abrams SI, Repasky EA. Kokolus KM, et al. Among authors: repasky ea. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20176-81. doi: 10.1073/pnas.1304291110. Epub 2013 Nov 18. Proc Natl Acad Sci U S A. 2013. PMID: 24248371 Free PMC article.

2

Translocation of spectrin and protein kinase C to a cytoplasmic aggregate upon lymphocyte activation.

Gregorio CC, Kubo RT, Bankert RB, Repasky EA. Gregorio CC, et al. Among authors: repasky ea. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4947-51. doi: 10.1073/pnas.89.11.4947. Proc Natl Acad Sci U S A. 1992. PMID: 1375753 Free PMC article.

3

Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.

Ghamande S, Hylander BL, Oflazoglu E, Lele S, Fanslow W, Repasky EA. Ghamande S, et al. Among authors: repasky ea. Cancer Res. 2001 Oct 15;61(20):7556-62. Cancer Res. 2001. PMID: 11606394

4

Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice.

Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA. Naka T, et al. Among authors: repasky ea. Cancer Res. 2002 Oct 15;62(20):5800-6. Cancer Res. 2002. PMID: 12384541

5

The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice.

Hylander BL, Pitoniak R, Penetrante RB, Gibbs JF, Oktay D, Cheng J, Repasky EA. Hylander BL, et al. Among authors: repasky ea. J Transl Med. 2005 May 19;3(1):22. doi: 10.1186/1479-5876-3-22. J Transl Med. 2005. PMID: 15943879 Free PMC article.

6

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K. Hylander B, et al. Gynecol Oncol. 2006 Apr;101(1):12-7. doi: 10.1016/j.ygyno.2005.09.052. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16263157

7

Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL.

Cheng J, Hylander BL, Baer MR, Chen X, Repasky EA. Cheng J, et al. Among authors: repasky ea. Mol Cancer Ther. 2006 Jul;5(7):1844-53. doi: 10.1158/1535-7163.MCT-06-0050. Mol Cancer Ther. 2006. PMID: 16891471

8

The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis.

Mace TA, Yamane N, Cheng J, Hylander BL, Repasky EA. Mace TA, et al. Among authors: repasky ea. Immunol Invest. 2006;35(3-4):279-96. doi: 10.1080/08820130600745463. Immunol Invest. 2006. PMID: 16916755 Review.

9

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery.

Kowalczyk A, Wierzbicki A, Gil M, Bambach B, Kaneko Y, Rokita H, Repasky E, Fenstermaker R, Brecher M, Ciesielski M, Kozbor D. Kowalczyk A, et al. Cancer Immunol Immunother. 2007 Sep;56(9):1443-58. doi: 10.1007/s00262-007-0289-0. Epub 2007 Feb 14. Cancer Immunol Immunother. 2007. PMID: 17597331 Free PMC article.

10

Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.

Xu Y, Choi J, Hylander B, Sen A, Evans SS, Kraybill WG, Repasky EA. Xu Y, et al. Among authors: repasky ea. Int J Hyperthermia. 2007 Sep;23(6):513-27. doi: 10.1080/02656730701666112. Int J Hyperthermia. 2007. PMID: 17952765 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters